| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327302 | Gynecologic Oncology | 2005 | 4 Pages |
Abstract
DMAPÂ +Â sargramostim produced a 27.8% RR, but its complexity and toxicity precluded further investigation, and the study was closed after the first stage of accrual.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Harry J. III, John A. Blessing, Joel Sorosky,